What is the current value of the structural heart devices market?

The structural heart devices market size stands at USD 13.81 billion in 2025 and is forecast to reach USD 21.48 billion by 2030. Read More

Which product segment generates the largest revenue?

Heart valve devices dominate with 60.0% of 2024 revenue, underpinned by sustained TAVR growth. Read More

How fast are transcatheter repair procedures growing?

Transcatheter repair, including MitraClip and TriClip, is expanding at a 14.2% CAGR through 2030, making it the fastest-growing procedural class. Read More

Why are ambulatory surgical centers important to future growth?

ASCs provide cost-effective, same-day discharge pathways and are growing at 12.5% CAGR, shifting demand away from traditional hospital settings. Read More

Which region shows the highest growth potential?

Asia-Pacific leads with an 11.1% forecast CAGR, propelled by rising procedure volumes in China and India. Read More

Who are the major players in this market?

Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation lead with a combined share above 70.0%, supported by broad portfolios and extensive clinical evidence programs. Read More

Global Structural Heart Devices Companies

This report lists the top Global Structural Heart Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Structural Heart Devices industry.